Geoffrey A. Pietersz

Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors

Theodora Fifis, Anita Gamvrellis, Blessing Crimeen‐Irwin et al. · The Journal of Immunology · 2004 · 664 citations · Full text

Veterinary Medicine, Cancer Biology, Immunology +17

Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.

Vasso Apostolopoulos, Geoffrey A. Pietersz, Bruce E. Loveland et al. · Proceedings of the National Academy of Sciences · 1995 · 190 citations

Life Sciences, Immunology, Oncology +17

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]

Vasso Apostolopoulos, Geoffrey A. Pietersz, Anastasios Tsibanis et al. · Breast Cancer Research · 2006 · 172 citations · Full text

Medicine, Immunology, Oncology +13

Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma

Bruce E. Loveland, Anne Zhao, Shane White et al. · Clinical Cancer Research · 2006 · 171 citations

Life Sciences, Immunology, Oncology +16

Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity <i>in vitro</i> and <i>in vivo</i>

Kuo‐Ching Sheng, Martha Kalkanidis, Dodie Pouniotis et al. · European Journal of Immunology · 2008 · 155 citations · Full text

Life Sciences, Bioengineering, Immunology +17